Cargando…
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
[Image: see text] Tumors are phenotypically heterogeneous and include subpopulations of cancer cells with stemlike properties. The natural product salinomycin, a K(+)-selective ionophore, was recently found to exert selectivity against such cancer stem cells. This selective effect is thought to be d...
Autores principales: | Huang, Xiaoli, Borgström, Björn, Stegmayr, John, Abassi, Yasmin, Kruszyk, Monika, Leffler, Hakon, Persson, Lo, Albinsson, Sebastian, Massoumi, Ramin, Scheblykin, Ivan G., Hegardt, Cecilia, Oredsson, Stina, Strand, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026786/ https://www.ncbi.nlm.nih.gov/pubmed/29974072 http://dx.doi.org/10.1021/acscentsci.8b00257 |
Ejemplares similares
-
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
por: Huang, Xiaoli, et al.
Publicado: (2016) -
Influence of salinomycin treatment on division and movement of individual cancer cells cultured in normoxia or hypoxia evaluated with time-lapse digital holographic microscopy
por: Kamlund, Sofia, et al.
Publicado: (2017) -
Extracellular and intracellular small-molecule galectin-3 inhibitors
por: Stegmayr, John, et al.
Publicado: (2019) -
Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
por: Stegmayr, John, et al.
Publicado: (2016) -
Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)